PANEL: Achieve New Heights in HPV Vaccination Rates: Start at Age 9 - Dr. Melissa Gilkey

Описание: Data continue to show the HPV vaccine is safe and effective, yet HPV vaccination rates remain well below national goals and other vaccines that are part of the “adolescent platform.” What can the evidence tell us about the potential benefits and challenges of routinely starting HPV vaccination at age nine? Would starting HPV vaccination at age nine increase HPV uptake and on-time completion? Are providers willing to recommend HPV vaccine at age nine and is it an easier interaction with parents when they do? What does this practice look like in an actual clinic? This panel will explore answers to these questions and more.

About Dr. Melissa Gilkey

Melissa Gilkey is a social and behavioral scientist in the University of North Carolina's Gillings School of Global Public Health. With research interests in adolescent health, cancer prevention and health services research, Dr. Gilkey studies individual, interpersonal and organizational approaches to improving the delivery of adolescent vaccines, including HPV vaccine. Her work includes survey research to understand barriers to vaccination, such as provider and parental hesitancy, as well as intervention research aimed at improving vaccine delivery systems.

------------------

▶︎ Subscribe to HPV Roundtable TV: https://bit.ly/33ymwpu

The Human Papillomavirus (HPV) vaccination can help prevent 6 types of cancer. Find accurate, evidence-based information about the HPV vaccine, virus, cancer prevention, and science from National HPV Vaccination Roundtable. Hosted by the American Cancer Society, the National HPV Vaccination Roundtable includes experts from 70+ immunization organizations representing nonprofits, universities, researchers, cancer survivors, and healthcare providers.

For more from the National HPV Roundtable:
▶︎ Visit Our Website: https://hpvroundtable.org/
▶︎ Like Us on Facebook:   / hpvroundtable  
▶︎ Follow Us on Twitter:   / hpvroundtable